REVENUES

6 Months Ended

Jun. 30, 2019

REVENUES

REVENUES

NOTE 5 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Six Months Ended June 30,
(U.S. dollars in thousands)		2019		2018
Pfizer	$	2,735	$	3,986
Brazil	$	4,225	$	2,573
Total revenues from selling goods	$	6,960	$	6,559
Revenues from license and R&D services	$	15,726	$	4,993

The following table sets forth data regarding the Company’s contracts liability:

	Six Months Ended June 30,
(U.S. dollars in thousands)	2019		2018
Contracts liability at the beginning of the period	$	42,895	$	25,015
Additions during the period		15,284		5,034
Revenue recognized during the period		(15,726)		(4,993)
Contracts liability at the end of the period	$	42,453	$	25,056

The following table represents the Company’s unsatisfied performance obligation:

	June 30,
(U.S. dollars in thousands)	2019		2018
Unsatisfied performance obligation	$	57,480	$	88,171